Laurel Sockrider
Family · Surprise, AZNPI 1881132314
Payments from drug & device makers
Across 122 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$489
- Novo Nordisk$398
- AbbVie$268
- Otsuka America Pharmaceutical, Inc.$224
- Abbott$182
- Lundbeck LLC$134
- plus $974 from 20 others
What the payments were for
- Food & beverage$2,668100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $489 |
| Novo Nordisk | 15 | $398 |
| AbbVie | 14 | $268 |
| Otsuka America Pharmaceutical, Inc. | 11 | $224 |
| Abbott | 6 | $182 |
| Lundbeck LLC | 7 | $134 |
| Lilly USA, LLC | 8 | $126 |
| Amgen | 7 | $120 |
| GSK | 6 | $108 |
| Aimmune Therapeutics, Inc. | 4 | $99 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $58 |
| Pfizer | 3 | $58 |
| Exact Sciences | 3 | $57 |
| Boehringer Ingelheim | 2 | $40 |
| Eisai Inc. | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Novartis | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Mylan Specialty L.p. | 1 | $28 |
| Almatica Pharma LLC | 1 | $27 |
| Radius Health, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Painteq LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,668 in reported general payments places this provider in the 85th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 75 | $90,162 |
| EliquisApixaban | 74 | $65,216 |
| OzempicSemaglutide | 33 | $53,100 |
| TrulicityDulaglutide | 14 | $22,762 |
| XareltoRivaroxaban | 17 | $20,946 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $20,939 |
| JardianceEmpagliflozin | 15 | $19,606 |
| CreonLipase/Protease/Amylase | 12 | $17,072 |
| LinzessLinaclotide | 15 | $15,751 |
| FarxigaDapagliflozin Propanediol | 15 | $15,375 |
| Spiriva HandihalerTiotropium Bromide | 22 | $12,842 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $9,161 |
| Rosuvastatin Calcium | 259 | $4,026 |
| Levothyroxine Sodium | 295 | $3,683 |
| Escitalopram Oxalate | 168 | $3,198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $126 | $112,92489 claims |
| PfizerEliquis | $58 | $65,21674 claims |
| Novo NordiskOzempic | $398 | $53,10033 claims |
| AbbVieCreon, Linzess, Synthroid | $268 | $34,77364 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $40 | $28,76727 claims |
| GSKTrelegy Ellipta | $108 | $20,93922 claims |
| AstraZenecaFarxiga | $489 | $15,37515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,119 family providers in Arizona.
Other family in Surprise
- Katherine RivasSurprise$34K
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Rebecca McCollaumMesa$149K
- Susan SarabiaSun City West$114K
- Lindsay CarterTucson$108K
- Audrey StevensonPhoenix$83K
- Keith MorsePrescott$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.